News Archive
The George Washington University (GW) Cancer Center and the GW School of Medicine and Health Sciences (SMHS) will have a large presence at the upcoming American Academy of Dermatology Association (AAD) Annual Meeting. The meeting will be held at the Walter E. Washington Convention Center in…
A team from the George Washington University (GW) Cancer Center has been approved for a $300,000 funding award through the Eugene Washington PCORI Engagement Awards (Engagement Awards) program, an initiative of the Patient-Centered Outcomes Research Institute (PCORI).
Dr. Papa is an expert in engineering novel therapeutic platforms at the intersection of chemistry, biology and medicine. Her work in the School of Engineering and Applied Science focuses on disease processes, particularly in cancer and vascular diseases, with the goal of designing targeted…
The George Washington University (GW) Cancer Center is pleased to announce the expansion of the Cutaneous Oncology Multidisciplinary Program. The program will bring together dermatologists, dermatologic surgeons, medical, surgical and radiation oncologists, and pathologists to provide…
A new reversible, drug-free antiplatelet therapy could reduce the risk of blood clots and potentially prevent cancer metastasis, according to a study published today in Science Translational Medicine.
When Mariam Said reflects on her cancer story she is reminded of what truly matters in life, “For me it’s my family and my health. I remember the shock when I first learned I had breast cancer. The pace at which my life changed was frightening, especially with three young children to think about…
The GW Cancer Center hosts a monthly breast cancer disparities work group to facilitate connections across the University between researchers, clinicians and members of the community, including survivors and caregivers.
WASHINGTON (Jan. 28, 2018) - A team from the George Washington University (GW) Cancer Center has engineered a nanoimmunotherapy that combines the advantages of nanotechnology and immunotherapy to treat cancer.
Members of the George Washington University (GW) Cancer Center, including Mandi Pratt-Chapman, MA, associate center director for patient-centered initiatives and health equity, recently published several journal articles and patient-focused pieces highlighting the GW Cancer Center’s work in…
Tommy Ballard has been with GW since 2013 and manages the operational and administrative functions for the GW Cancer Center's clinical programs.
What brought you to GW?